E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.
about
E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition.Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression.CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer.MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.Diagnostic impact of promoter methylation and E-cadherin gene and protein expression levels in laryngeal carcinoma.DNA methylation of E-cadherin is a priming mechanism for prostate development.MiR-199a-5p loss up-regulated DDR1 aggravated colorectal cancer by activating epithelial-to-mesenchymal transition related signaling.α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma.Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and PromisesPhysical Mechanisms of Cancer in the Transition to Metastasis.
P2860
Q34037623-B529B89D-E2AD-43A2-8037-73A8A1ACE973Q34556770-65196749-F64E-4BA7-80D7-CD625959067FQ34717946-B677ECF4-74E9-45A8-9BB7-22FEB4A7CA13Q36741554-94B86108-2070-4C5C-9FE7-5FC36CB2AA4CQ37086059-05680FCC-63AC-4D6C-A94B-67EF26D6CBA6Q37601968-01C8D15C-899D-46E3-A503-02FD9CFA301CQ37686939-999784BA-18AB-45AF-AE68-7FDD310E0708Q39006701-95366F95-7BAB-432A-9936-050593A142C0Q39027184-B41DB91D-7BF9-4726-ACB7-EB00CB1CC04DQ39048777-1FCD4FAF-B2D7-43BB-B407-278DDEC6659EQ41664067-A1DA9ED3-511C-4F92-B6B7-777269DAB694Q41769018-8855EA92-C437-423B-AEE0-CB55AD5C7F7D
P2860
E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
E-cadherin promotor methylatio ...... pacity of breast cancer cells.
@ast
E-cadherin promotor methylatio ...... pacity of breast cancer cells.
@en
E-cadherin promotor methylatio ...... pacity of breast cancer cells.
@nl
type
label
E-cadherin promotor methylatio ...... pacity of breast cancer cells.
@ast
E-cadherin promotor methylatio ...... pacity of breast cancer cells.
@en
E-cadherin promotor methylatio ...... pacity of breast cancer cells.
@nl
prefLabel
E-cadherin promotor methylatio ...... pacity of breast cancer cells.
@ast
E-cadherin promotor methylatio ...... pacity of breast cancer cells.
@en
E-cadherin promotor methylatio ...... pacity of breast cancer cells.
@nl
P2093
P2860
P1476
E-cadherin promotor methylatio ...... pacity of breast cancer cells.
@en
P2093
Alexander M M Eggermont
Joost A P Rens
Mieke Schutte
Remco van Horssen
Timo L M Ten Hagen
P2860
P2888
P304
P356
10.1007/S10549-012-2261-8
P407
P577
2012-09-29T00:00:00Z
P5875
P6179
1004811302